B of A Securities Maintains Underperform on Core Laboratories, Lowers Price Target to $16
Portfolio Pulse from Benzinga Newsdesk
B of A Securities analyst Chase Mulvehill maintains an Underperform rating on Core Laboratories (NYSE:CLB) and lowers the price target from $17 to $16.

April 15, 2024 | 1:08 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
B of A Securities maintains an Underperform rating on Core Laboratories and lowers the price target from $17 to $16.
The adjustment in price target and maintenance of an Underperform rating by a significant analyst like Chase Mulvehill at B of A Securities suggests a bearish outlook on Core Laboratories. This could lead to a negative short-term impact on the stock price as market participants react to the analyst's expectations of underperformance.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100